BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28724763)

  • 1. Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.
    Zhang L; Morikis D
    Biophys J; 2006 May; 90(9):3106-19. PubMed ID: 16473914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
    Ganesh VK; Smith SA; Kotwal GJ; Murthy KH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8924-9. PubMed ID: 15178763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.
    Benhnia MR; McCausland MM; Laudenslager J; Granger SW; Rickert S; Koriazova L; Tahara T; Kubo RT; Kato S; Crotty S
    J Virol; 2009 Dec; 83(23):12355-67. PubMed ID: 19793826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.
    Moulton EA; Bertram P; Chen N; Buller RM; Atkinson JP
    J Virol; 2010 Sep; 84(18):9128-39. PubMed ID: 20610727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the vaccinia virus complement control protein (VCP) in the rat retina.
    Fernando N; Natoli R; Racic T; Wooff Y; Provis J; Valter K
    PLoS One; 2018; 13(3):e0193740. PubMed ID: 29534078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay (ELISA) and blocking with bovine serum albumin (BSA)--not all BSAs are alike.
    Xiao Y; Isaacs SN
    J Immunol Methods; 2012 Oct; 384(1-2):148-51. PubMed ID: 22732194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.
    Okada H; Wakamiya N; Okada N; Kato S
    Cancer Immunol Immunother; 1987; 25(1):7-9. PubMed ID: 3594492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of a functional variant hFGF7 with enhanced properties by circular permutation.
    Choi HJ; Lee H; Cheong DE; Yoo SK; Lee DE; Kim GJ
    Biotechnol J; 2024 Mar; 19(3):e2300712. PubMed ID: 38528341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-Encoded Complement Regulators: Current Status.
    Sinha A; Singh AK; Kadni TS; Mullick J; Sahu A
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33573085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthopoxvirus K3 orthologs show virus- and host-specific inhibition of the antiviral protein kinase PKR.
    Park C; Peng C; Rahman MJ; Haller SL; Tazi L; Brennan G; Rothenburg S
    PLoS Pathog; 2021 Jan; 17(1):e1009183. PubMed ID: 33444388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatially conserved motifs in complement control protein domains determine functionality in regulators of complement activation-family proteins.
    Ojha H; Ghosh P; Singh Panwar H; Shende R; Gondane A; Mande SC; Sahu A
    Commun Biol; 2019; 2():290. PubMed ID: 31396570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules.
    Yadav VN; Pyaram K; Ahmad M; Sahu A
    J Immunol; 2012 Aug; 189(3):1431-9. PubMed ID: 22732591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.
    Rosengard AM; Liu Y; Nie Z; Jimenez R
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8808-13. PubMed ID: 12034872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variola virus immune evasion proteins.
    Dunlop LR; Oehlberg KA; Reid JJ; Avci D; Rosengard AM
    Microbes Infect; 2003 Sep; 5(11):1049-56. PubMed ID: 12941397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia complement control protein: multi-functional protein and a potential wonder drug.
    Jha P; Kotwal GJ
    J Biosci; 2003 Apr; 28(3):265-71. PubMed ID: 12734405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
    Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.
    Yadav VN; Pyaram K; Mullick J; Sahu A
    J Virol; 2008 Apr; 82(7):3283-94. PubMed ID: 18216095
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.